Rocket Digital Health

Most DTC healthcare companies don’t fail because the product is bad.

They fail because the economics quietly stop working.

CAC creeps up. Retention looks fine—until you realize it’s compensating for acquisition fragility. Brand stops compounding and starts renting attention from Meta, Google, and Apple. Growth becomes spend-driven instead of insight-driven.

At that point, teams start saying the phrase that sounds strategic but usually isn’t:

“We should go B2B2C.”

Sometimes that’s right. Often it’s disastrously wrong.

This post is about how to make that shift intentionally—and when not to make it at all.

How to Shift from Direct-to-Consumer Healthcare to B2B2C — Rocket Digital Health How to Shift from Direct-to-Consumer Healthcare to B2B2C. A practical guide for founders who’ve hit the DTC ceiling—and know it.

Where smart money is flowing, how regulatory shifts shape exits, and actionable strategy tips for founders, LPs, and corporate innovation teams. This long but readable review distills insights from founders, respected VCs, ex-big Pharma BD chiefs, policy economists, and data scientists who track deals $5 million across digital health, biotech, devices, and care-delivery.

A Healthcare Venture Capital Report: 2025 — Rocket Digital Health 2025 healthcare venture capital trends: where money is flowing, how exits are shaping up, and actionable strategy tips for founders, LPs, and corporate innovation teams.